NKILA and cholangiocarcinoma: Mechanistically, NKILA was identified as a competing endogenous RNA (ceRNA) for miR-582-3p; thus ‘sponging miR-582-3p, and relieving its repression of YAP1 protein expression, a driver of CCA [227].